来自iPSC的T细胞和巨细胞:制造和下一代应用方法
Débora Basílio-Queirós1, Isabelle Rivière2, Sjoukje J C van der Stegen3
1Department of Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School, Hannover, Germany.
Advanced drug delivery reviews
|October 15, 2025
概括
诱导多能干细胞 (iPSC) 为基于CAR的免疫疗法提供了一个可再生的来源,克服了治疗各种癌症的可扩展性和供体变异性方面的挑战. 这种方法提高了对专门免疫细胞的可访问性,以改善癌症治疗策略.
科学领域:
- 免疫治疗是一种免疫疗法.
- 干细胞生物学 干细胞生物学
- 在瘤学瘤学.
背景情况:
- 化学抗原受体 (CAR) 技术在治疗血液癌症方面表现有前途,但在固体瘤,可扩展性和供体变异性方面面临局限性.
- 诱导多能干细胞 (iPSC) 技术为开发基于CAR的疗法提供了一种可再生和可适应的来源.
- 目前的CAR疗法通常依赖于自主或异种来源,在制造和可访问性方面存在挑战.
研究的目的:
- 审查最近在iPSC衍生的CAR-T细胞和CAR-巨细胞癌症免疫疗法的进展.
- 讨论差异化,基因工程和缓解免疫排斥 (移植与宿主疾病) 的策略.
- 探索iPSCs在产生多样化的免疫细胞种群中的潜力,以获得更广泛的治疗应用.
主要方法:
- 对免疫细胞的iPSC分化协议的当前文献的综述.
- 对基因工程技术的分析,以在iPSC衍生细胞中实现CAR表达.
- 检查解决组织相容性和免疫相容性的策略.
主要成果:
- iPSCs为CAR-T和CAR-巨细胞疗法提供了一个可扩展的,现成的来源.
- 开发用于生成iPSC衍生的免疫细胞的协议,包括T细胞,巨细胞和不太常见的群体,如NKT和微质细胞.
- 缓解移植对宿主疾病 (GvHD) 和克服基因相容性障碍的策略正在推进.
结论:
- 来自iPSC的CAR疗法在克服当前免疫疗法的局限性方面取得了重大进展.
- 这些疗法具有治疗固体瘤的潜力,并提高了获得专门免疫细胞产品的机会.
- 需要进一步的研究和临床验证才能充分实现基于iPSC的癌症治疗的潜力.
更多相关视频
10:44A Three-dimensional Thymic Culture System to Generate Murine Induced Pluripotent Stem Cell-derived Tumor Antigen-specific Thymic Emigrants
Published on: August 9, 2019
7.6K
10:57Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells
Published on: October 24, 2019
10.9K
相关概念视频
01:22iPS Cell Differentiation
3.0K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.0K
01:13Induced Pluripotent Stem Cells
27.2K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
27.2K
01:21EPS and iPS Cells in Disease Research
3.4K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.4K